Ribonucleic acid-based therapy for Diabetes: LncRNA C2dat1 increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 19/March/2019, 6.49 am